Limbix
Palo Alto
About Limbix
Limbix is a prescription digital therapeutic company passionate about creating mental health treatments for adolescents. The Limbix team is uniquely suited to develop prescription digital therapeutics, as its diverse team of clinicians, product designers, researchers, and engineers understand the value of pairing clinical expertise with technological innovation. Their first digital therapeutic, SparkRx by Limbix, is available for licensed healthcare professionals to offer to patients nationwide. For more information about Limbix and SparkRx, please visit limbix.com and SparkRx.com.
Company Facts
- Operating status: Closed
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: $1K – $10K
- Total funding: $31.0M
- Funding stage: M&A
- Last round: Series A (Dec 2021)
- Website: limbix.com
- Phone: (888) 546-2495
Industries & Categories
Biotechnology, Health Care, Medical, Medical Device, Mental Health
Social Profiles
Canonical: https://fsome.com/organization/limbix-70577 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.